Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.4100
+0.1573 (62.25%)
At close: Feb 23, 2026, 4:00 PM EST
0.3800
-0.0300 (-7.32%)
After-hours: Feb 23, 2026, 7:59 PM EST
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $30.15 million as of February 23, 2026. Its market cap has increased by 209.26% in one year.
Market Cap
30.15M
Enterprise Value
17.68M
1-Year Change
209.26%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $30.15M, a decrease of -76.32%. That is a compound annual growth rate of -31.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 18.58M | -11.36% |
| Dec 31, 2025 | 20.96M | 103.27% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 20.75M |
| VYNE Therapeutics | 19.80M |
| Anebulo Pharmaceuticals | 19.29M |
| Pasithea Therapeutics | 18.47M |
| Jupiter Neurosciences | 17.90M |
| Serina Therapeutics | 17.47M |
| FibroBiologics | 16.50M |
| Hoth Therapeutics | 16.29M |